Public Profile

Zhejiang Int'l Medicine Co., Ltd.

Zhejiang Int'l Medicine Co., Ltd., commonly referred to as Zhejiang Medicine, is a prominent player in the pharmaceutical industry, headquartered in China. Established in 1995, the company has made significant strides in the development and distribution of high-quality medicinal products, primarily focusing on APIs (Active Pharmaceutical Ingredients) and finished dosage forms. With a strong operational presence across Asia and expanding into international markets, Zhejiang Medicine is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of generic drugs and specialty pharmaceuticals, distinguished by their adherence to stringent regulatory standards. Recognised for its robust market position, Zhejiang Int'l Medicine has achieved notable milestones, including certifications from global health authorities, which underscore its dedication to excellence in healthcare solutions.

DitchCarbon Score

How does Zhejiang Int'l Medicine Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

10

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Zhejiang Int'l Medicine Co., Ltd.'s score of 10 is higher than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.

75%

Zhejiang Int'l Medicine Co., Ltd.'s reported carbon emissions

Zhejiang Int'l Medicine Co., Ltd., headquartered in China, currently does not have available carbon emissions data for recent years, nor does it specify any reduction targets or initiatives. Without specific emissions figures or commitments, it is unclear how the company is addressing its carbon footprint or contributing to climate action within the pharmaceutical industry. As the global focus on sustainability intensifies, it is essential for companies like Zhejiang Int'l Medicine to establish clear climate commitments and measurable targets to enhance their environmental responsibility and align with industry standards.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zhejiang Int'l Medicine Co., Ltd.'s primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Zhejiang Int'l Medicine Co., Ltd. is headquartered in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zhejiang Int'l Medicine Co., Ltd. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Shanghai Pharmaceuticals

CN
Health and social work services (85)
Updated 5 days ago

CHINA NATIONAL PHARMACEUTICAL GROUP

CN
Chemicals nec
Updated 2 days ago

Huadong Medicine Co., Ltd

CN
Chemicals nec
Updated 5 days ago

Sichuan Kelun Medicine & Trade Co., Ltd.

CN
Chemicals nec
Updated 5 days ago
DitchCarbon Score

Nanjing Pharmaceutical

CN
Health and social work services (85)
Updated 5 days ago

Wanjia Group Holdings Limited

HK
Chemicals nec
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers